[Mature teratoma following chemotherapy in bilateral testicular tumors--a critical contribution].
The histological treatment of preparations of the retroperitoneal lymphadenectomy (RLA) after chemotherapy of non-seminomatous testicular tumours results in about 25% of the cases in the evidence of the "mature teratoma". An own observation suggests that a prognostically favourable valuation of this diagnosis is justified not without restriction.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002369:Castration; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D003131:Combined Modality Therapy; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000473:pathology*; D011379:Prognosis; D013724:Teratoma / Q000188:drug therapy / Q000473:pathology*; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000473:pathology*; D013737:Testis / Q000473:pathology
D000970:Antineoplastic Agents
Reifes Teratom nach Chemotherapie bei einem bilateralen Hodentumor--ein kritischer Beitrag.